/
Not financial advice. Analytical data for research only.
Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.
Markel Group is a holding company that owns independently operated businesses across a range of industries. The cornerstone business, Markel Insurance, provides specialized insurance products that are not typically available through the standard insurance market.
$1,797.28
$5.63 (-0.31%)
EOD Sep 1, 2026
Net margin is thin at 13.58%. This may reflect rising credit costs, rate compression, or operational inefficiency.
Revenue growth slowed to 4.7%, essentially flat. This is a business that needs a catalyst.
Net income declined 23% YoY, profitability momentum has weakened.
9.9x earnings. Below the sector average, the market may be pricing in credit losses or regulatory headwinds, or there's genuine value here.
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (TTM)
$15.51B
▲ +4.7% YoY
Net Income (TTM)
$2.28B
▼ -23.3% YoY
Net Margin
14.73%
P/E
9.9x
Balance Sheet
Total Assets
$71.26B
Equity
$19.01B
Total Debt
$4.37B
Cash & Equiv.
$5.76B
5Y CAGR: +9.8%
Continue Research
SourceComputed from the 10-Q filed 29 Jul 2026, covering the period ending 30 Jun 2026, as reported to the SEC. Data last refreshed 30 Jul 2026. How this is calculated.
Price from market data, last close as of 1 Sept 2026. Fiscal year ends Dec. Sector medians are approximate S&P 500 benchmarks and update periodically.
At a P/E of 9.9 and a price-to-free-cash-flow of 10.7, Markel Group (MKL) trades below a two-stage DCF intrinsic value of about $3,025.58 per share, so at $1,797.28 the stock looks undervalued (68.3% below estimated intrinsic value). A high multiple is not the same as overvalued: fast-growing, high-quality businesses can deserve a premium. See the general approach in how to tell if a stock is overvalued.
On quality, Markel Group scores 92/100 on Intrinsiqq's quality scorecard (a high-quality business on these measures), weighing growth, margins, returns on capital, share count, and balance-sheet strength. All figures are computed from SEC filings; read the full methodology. This is analysis, not investment advice.
Intrinsiqq's two-stage DCF estimates an intrinsic value of about $3,025.58 per share for MKL, projecting its recent free cash flow forward with a growth rate that fades toward a long-run rate and discounting it back to today. Applying a 25% margin of safety gives a more conservative fair-value entry around $2,269.18. At today's $1,797.28, that puts the stock about 68.3% below estimated intrinsic value. The result is sensitive to the growth and discount-rate inputs, so it is best to run conservative, base and optimistic cases. You can adjust all of them yourself with the sliders on the DCF tab.
Markel Group scores 92 out of 100 on Intrinsiqq's quality score, a weighted blend of 8 metrics each scored 0 to 100, which makes it a high-quality business on these measures. Recent fundamentals include a 19.9% operating margin and a 10.7% return on invested capital. The score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, share-count change, and balance-sheet strength, all computed from SEC filings, not opinion. Because valuation only means something relative to quality, the full metric-by-metric breakdown is on the quality scorecard.
That depends on valuation and quality together, not either alone. MKL currently trades below its estimated intrinsic value and scores 92/100 on quality (high-quality). A cheap price is only a bargain if the business is durable, and a premium can be justified by genuine quality, so the two questions, "is it cheap?" and "is it good?", only make sense side by side. Read the valuation against the quality scorecard, run the DCF on your own assumptions, and decide for yourself. This is analysis from SEC filings, not investment advice.